Rona Therapeutics licenses an obesity drug candidate to Roche in a deal worth up to $1.16B
Rona gets up to $100 million upfront and in near-term milestones, with up to $1.06 billion more possible as the program advances.
Recap by typeshit. Full story at RTTNews.